UrFU researchers will create methods for targeted delivery of cancer drugs

| By | Cancer Drugs, Radiopharmaceuticals

The scientists at the Cyclotron Center for Nuclear Medicine of the Ural Federal University (UrFU) will design new methods for targeted delivery of drugs to the malignant tumor location. Together with their colleagues from the Ural State Medical University (USMU), they will also train medical radiologists and retrain the doctors of other specialties.

“This year, UFU plans to commission such a complex facility as the Cyclotron Center for Nuclear Medicine. We believe that at least two things are required for the effective treatment of oncological diseases – to detect the “enemy” as quickly and accurately as possible, and destroy it with maximum precision. All this will be the focus of newly established Center. One of the stages in development of the Center will be the creation of a scientific platform so that we can search for new methods aimed primarily at the targeted delivery of radiopharmaceuticals to the tumor location,” said Sergey Bazhukov, the Director of the Cyclotron Center for Nuclear Medicine at UFU.

He added that the technical launch of the cyclotron is expected by July 2018 and all documents necessary for continuous operation of the Center will be prepared by the end of the year. In addition to the colleagues from USMU, the work of the Center will involve the representatives of the Institute of Organic Synthesis of the Ural Branch of the Russian Academy of Sciences, as well as other scientific organizations and industrial enterprises of the region.